Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC
- Status
- COMPLETED
- Phase
- N/A
Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.
- Status
- RECRUITING
- Phase
- PHASE3
PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
The Dual Impact of Cirrhosis on Transplantation for Hepatocellular Carcinoma：a Two-center Retrospective Cohort Study in China
- Status
- COMPLETED
- Phase
- N/A
Vienna Hypothermic Oxygenated Machine Perfusion Study
- Status
- RECRUITING
- Phase
- N/A
Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver Transplantation
- Status
- COMPLETED
- Phase
- N/A
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma
- Status
- SUSPENDED
- Phase
- PHASE2
Clinical Trial of TB511 in Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
- Status
- RECRUITING
- Phase
- PHASE2
Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy
- Status
- RECRUITING
- Phase
- N/A
Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy
- Status
- RECRUITING
- Phase
- N/A
Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.
- Status
- RECRUITING
- Phase
- PHASE2
A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1